北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第一临床医学院  > 肿瘤化疗科  > 期刊论文
学科主题: 临床医学
题名:
Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies
作者: Yu, Hongliang1,2; Yin, Li1,2; Jiang, Xuesong1,2; Sun, Xiujin1,2; Wu, Jing1,2; Tian, Hao1,2; Gao, Xianshu3; He, Xia1,2
刊名: PLOS ONE
发表日期: 2014-12-29
DOI: 10.1371/journal.pone.0116327
卷: 9, 期:12
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Multidisciplinary Sciences
研究领域[WOS]: Science & Technology - Other Topics
关键词[WOS]: DIABETIC-PATIENTS ; INCIDENT CANCER ; CLINICAL-TRIALS ; BREAST-CANCER ; SULFONYLUREA ; MORTALITY ; COHORT ; SURVIVAL ; IMPACT ; BIAS
英文摘要:

Background: Laboratory studies have shown the anti-tumor effect of metformin on prostate cancer. However, recent epidemiological studies have yielded inconclusive results.

Methods: We searched PubMed database from the inception to May 30 2014 for studies which assessed the effect of metformin use on cancer risk of prostate cancer, biochemical recurrence (BCR) and all-cause mortality of patients with prostate cancer. The pooled results and 95% confidence intervals (CIs) were estimated by random-effect model.

Results: Twenty-one studies were eligible according to the inclusion criteria. Based on the pooled results of available observational studies, metformin use was significantly associated with a decreased cancer risk (14 datasets, 963991 male subjects, odds ratio: 0.91, 95% CI: 0.85-0.97) and BCR (6 datasets, 2953 patients, hazard ratio: 0.81, 95% CI: 0.68-0.98) of prostate cancer. However, the association of metformin use with all-cause mortality of patients with prostate cancer was not significant (5 datasets, 9241 patients, hazard ratio: 0.86, 95% CI: 0.64-1.14).

Conclusion: Results suggest that metformin use appears to be associated with a significant reduction in the cancer risk and BCR of prostate cancer, but not in all-cause mortality of patients with prostate cancer.

语种: 英语
所属项目编号: BK20141018 ; BRA2013292 ; WS-047 ; 30670619 ; 81072017
项目资助者: Jiangsu Provincial Natural Science Fund ; "333" Project of Jiangsu Province ; Six Major Talent Peak Project of Jiangsu Province ; Natural Science Foundation of China
WOS记录号: WOS:000347120200112
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/60868
Appears in Collections:北京大学第一临床医学院_肿瘤化疗科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Canc Hosp, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China
2.Nanjing Med Univ, Affiliated Canc Hosp, Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China
3.Peking Univ, Hosp 1, Dept Radiat Oncol, Beijing 100871, Peoples R China

Recommended Citation:
Yu, Hongliang,Yin, Li,Jiang, Xuesong,et al. Effect of Metformin on Cancer Risk and Treatment Outcome of Prostate Cancer: A Meta-Analysis of Epidemiological Observational Studies[J]. PLOS ONE,2014,9(12).
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Yu, Hongliang]'s Articles
[Yin, Li]'s Articles
[Jiang, Xuesong]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Yu, Hongliang]‘s Articles
[Yin, Li]‘s Articles
[Jiang, Xuesong]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace